Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term imprisonment leads to cognitive impairment.
Lapornik R, Lehofer M, Moser M, Pump G, Egner S, Posch C, Hildebrandt G, Zapotoczky HG. Lapornik R, et al. Among authors: posch c. Forensic Sci Int. 1996 Sep 30;82(2):121-7. doi: 10.1016/0379-0738(96)01985-8. Forensic Sci Int. 1996. PMID: 8885372
Primum non nocere: MelTUMP.
Posch C. Posch C. J Eur Acad Dermatol Venereol. 2023 May;37(5):849-850. doi: 10.1111/jdv.19006. J Eur Acad Dermatol Venereol. 2023. PMID: 37052428 No abstract available.
Melanoma is not just one disease, but many.
Posch C. Posch C. J Eur Acad Dermatol Venereol. 2023 May;37(5):847-848. doi: 10.1111/jdv.19008. J Eur Acad Dermatol Venereol. 2023. PMID: 37052427 No abstract available.
Hyperprogression of Merkel cell carcinoma after avelumab treatment.
Pirker R, Fink A, Stella A, Stifter L, Posch C. Pirker R, et al. Among authors: posch c. J Eur Acad Dermatol Venereol. 2023 May;37(5):e675-e677. doi: 10.1111/jdv.18887. Epub 2023 Jan 31. J Eur Acad Dermatol Venereol. 2023. PMID: 36662601 No abstract available.
Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland.
Schumann K, Mauch C, Klespe KC, Loquai C, Nikfarjam U, Schlaak M, Akçetin L, Kölblinger P, Hoellwerth M, Meissner M, Mengi G, Braun AD, Mengoni M, Dummer R, Mangana J, Sindrilaru MA, Radmann D, Hafner C, Freund J, Rappersberger K, Weihsengruber F, Meiss F, Reinhardt L, Meier F, Rainer B, Richtig E, Ressler JM, Höller C, Eigentler T, Amaral T, Peitsch WK, Hillen U, Harth W, Ziller F, Schatton K, Gambichler T, Susok L, Maul LV, Läubli H, Debus D, Weishaupt C, Börger S, Sievers K, Haferkamp S, Zenderowski V, Nguyen VA, Wanner M, Gutzmer R, Terheyden P, Kähler K, Emmert S, Thiem A, Sachse M, Gercken-Riedel S, Kaune KM, Thoms KM, Heinzerling L, Heppt MV, Tratzmiller S, Hoetzenecker W, Öllinger A, Steiner A, Peinhaupt T, Podda M, Schmid S, Wollina U, Biedermann T, Posch C. Schumann K, et al. Among authors: posch c. J Eur Acad Dermatol Venereol. 2023 May;37(5):894-906. doi: 10.1111/jdv.18779. Epub 2022 Dec 12. J Eur Acad Dermatol Venereol. 2023. PMID: 36433688
Dermatologie - Die Melange des Cafés.
Posch C. Posch C. J Dtsch Dermatol Ges. 2019 Apr;17(4):474-475. doi: 10.1111/ddg.13803. J Dtsch Dermatol Ges. 2019. PMID: 30958943 No abstract available.
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.
Feichtenschlager V, Chen L, Zheng YJ, Ho W, Sanlorenzo M, Vujic I, Fewings E, Lee A, Chen C, Callanan C, Lin K, Qu T, Hohlova D, Vujic M, Hwang Y, Lai K, Chen S, Nguyen T, Muñoz DP, Kohwi Y, Posch C, Daud A, Rappersberger K, Kohwi-Shigematsu T, Coppé JP, Ortiz-Urda S. Feichtenschlager V, et al. Among authors: posch c. Res Sq [Preprint]. 2023 Dec 1:rs.3.rs-1297358. doi: 10.21203/rs.3.rs-1297358/v3. Res Sq. 2023. PMID: 38077055 Free PMC article. Updated. Preprint.
162 results